More
    Guided Solutions - Connecting Talent With Innovation/div>

    Eitan Medical wins EU clearance for Sapphire infusion pump

    Eitan Medical announced that it received European Union Medical Device Recognition (MDR) certification for its Sapphire infusion pump. Approval for the Sapphire infusion pump, along with...

    Promaxo Receives 510(k) Clearance from the FDA for its Innovational MRI Platform

    Ready for commercial distribution, the first single-sided MRI, cleared for office setting, will be available in the United States. The United States Food and Drug...

    FDA gives Cue Health first EUA for at-home, OTC COVID-19 molecular testing

    The system delivers its results to a companion app in about 20 minutes, according to the agency. The FDA has issued its first emergency use...

    Relivion® Wearable Brain Neuromodulation Technology Cleared by FDA for the Treatment of Migraine

    Neurolief, an innovator in neurotechnology, announces the company has received Food and Drug Administration (FDA) clearance for its Relivion® system. Relivion® is the first non-invasive...

    Asensus Surgical scores general surgery clearance for its Senhance robot

    Shortly after TransEnterix changed its name to Asensus Surgical late last month—calling the rebranding a signal of its plans to bring artificial intelligence to...

    FDA clears first surgical robot for transvaginal hysterectomies

    The FDA cleared its first surgical robot designed for transvaginal hysterectomies, a minimally invasive option that aims for a faster recovery time compared to...

    Fusion Robotics™ Receives 510(k) Clearance for Spinal Navigation & Robotics System

    Fusion Robotics LLC, a spinal robotics and navigation company today announced receiving 510(k) clearance to market their 3D imaging compatible navigation and robotic targeting...

    J&J’s Covid-19 vaccine gets vote of confidence from FDA advisory panel

    The committee voted 22-0 on the question of whether the benefits of Johnson & Johnson's Covid-19 vaccine outweigh its risks. FDA emergency use authorization...

    Gala Therapeutics Receives FDA Approval to Commence Pivotal Trial to Evaluate the RheOx™ System for Chronic Bronchitis

    Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, announces U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption...

    Latest articles